Role of IL-18 in Crohn's Disease (CD) View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2000-2012

FUNDING AMOUNT

2327791 USD

ABSTRACT

Although the precise etiology is unknown, inflammatory bowel disease (IBD) is thought to occur as a result of a dysregulated mucosal immune response to environmental factors in a genetically predisposed individual. IL-18 is a cytokine that plays an important role in the pathogenesis of several chronic Thl-mediated disorders, including Crohn's disease (CD). In fact, a dramatic shift in IL-18 expression occurs during CD from intestinal epithelial cells (IEC) to mucosal immune cells (i.e. macrophages and dendritic cells), as the severity of disease increases. In addition, recent evidence supports the role of IL-18 as a protective factor during the acute phase of mucosal immune responses, when IEC are the primary source of IL-18. This novel function for IL-18 contrasts with the pathogenic role IL-18 is believed to play in more chronic phases of Thl-mediated inflammation. A genetic basis for differences in IL-18 regulation and expression observed in IBD may exist since recent studies have reported the association of specific single nucleotide polymorphisms (SNPs) in the IL-18 promoter region and several autoimmune diseases. Therefore, using genetic and molecular biology techniques as well as experimental models intestinal inflammation, the present study is designed to investigate the specific genetic factors that regulate IL-18 synthesis and to determine the precise function of epithelial and immune cell-derived IL-18 in the acute versus chronic phases of IBD. The central hypothesis of the present proposal is that IL-18plays a key role in regulating normal innate immune responses in the gut mucosa and dysregulation of IL-18 may result in chronic intestinal inflammation characteristic of IBD. The following three specific aims are proposed to test this hypothesis: 1) Determine the relationship between polymorphisms in the IL-18 promoter region and IBD. The role of IL-18 in IBD susceptibility will be defined using an association approach by screening for recently described IL-18 promoter polymorphisms and performing case association studies of these genetic markers in well-characterized IBD and control populations. IBD multiplex families will also be used to test linkage disequilibrium between these marker loci and putative disease susceptibility loci in order to further characterize the transmission pattern of allelic variants. 2) Define the mechanismCs) of polymorphic IL-18 gene regulation in different mucosal cell populations. The functional relevance of IL-18 promoter polymorphisms will be achieved by creation of reporter constructs, site-directed mutagenesis experiments, and in vitro transfection assays in epithelial and macrophage cell lines. In addition, differential transcription factor binding and subsequent transcriptional regulation will be assessed in order to determine how the IL- 18 gene is differentially regulated by IL-18 promoter polymorphisms, and if transcriptional control varies among different intestinal cell types. 3) Evaluate the specific role of IL-18 derived from different gut mucosal cell populations in an in vivo setting using experimental models of intestinal inflammation. The extent and severity of disease will be assessed in mice genetically- and immunologically-manipulated to produce IL-18 in either hemopoietic- (i.e. immune cells) or non-hemopoietic-cells (i.e. epithelial cells) following the induction of acute or chronic intestinal inflammation. These experiments will mechanistically address, in an in vivo setting, if IL-18 derived from specific mucosal cell populations and expressed during the acute versus chronic phases of disease, are involved in the pathogenesis of IBD. The ultimate goal of the present research proposal is to define the precise role of IL-18 in CD in order to develop specific treatment modalities aimed at modifying the natural course of this devastating disease. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=7682959

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "2327791"
    }, 
    "description": "Although the precise etiology is unknown, inflammatory bowel disease (IBD) is thought to occur as a result of a dysregulated mucosal immune response to environmental factors in a genetically predisposed individual. IL-18 is a cytokine that plays an important role in the pathogenesis of several chronic Thl-mediated disorders, including Crohn's disease (CD). In fact, a dramatic shift in IL-18 expression occurs during CD from intestinal epithelial cells (IEC) to mucosal immune cells (i.e. macrophages and dendritic cells), as the severity of disease increases. In addition, recent evidence supports the role of IL-18 as a protective factor during the acute phase of mucosal immune responses, when IEC are the primary source of IL-18. This novel function for IL-18 contrasts with the pathogenic role IL-18 is believed to play in more chronic phases of Thl-mediated inflammation. A genetic basis for differences in IL-18 regulation and expression observed in IBD may exist since recent studies have reported the association of specific single nucleotide polymorphisms (SNPs) in the IL-18 promoter region and several autoimmune diseases. Therefore, using genetic and molecular biology techniques as well as experimental models intestinal inflammation, the present study is designed to investigate the specific genetic factors that regulate IL-18 synthesis and to determine the precise function of epithelial and immune cell-derived IL-18 in the acute versus chronic phases of IBD. The central hypothesis of the present proposal is that IL-18plays a key role in regulating normal innate immune responses in the gut mucosa and dysregulation of IL-18 may result in chronic intestinal inflammation characteristic of IBD. The following three specific aims are proposed to test this hypothesis: 1) Determine the relationship between polymorphisms in the IL-18 promoter region and IBD. The role of IL-18 in IBD susceptibility will be defined using an association approach by screening for recently described IL-18 promoter polymorphisms and performing case association studies of these genetic markers in well-characterized IBD and control populations. IBD multiplex families will also be used to test linkage disequilibrium between these marker loci and putative disease susceptibility loci in order to further characterize the transmission pattern of allelic variants. 2) Define the mechanismCs) of polymorphic IL-18 gene regulation in different mucosal cell populations. The functional relevance of IL-18 promoter polymorphisms will be achieved by creation of reporter constructs, site-directed mutagenesis experiments, and in vitro transfection assays in epithelial and macrophage cell lines. In addition, differential transcription factor binding and subsequent transcriptional regulation will be assessed in order to determine how the IL- 18 gene is differentially regulated by IL-18 promoter polymorphisms, and if transcriptional control varies among different intestinal cell types. 3) Evaluate the specific role of IL-18 derived from different gut mucosal cell populations in an in vivo setting using experimental models of intestinal inflammation. The extent and severity of disease will be assessed in mice genetically- and immunologically-manipulated to produce IL-18 in either hemopoietic- (i.e. immune cells) or non-hemopoietic-cells (i.e. epithelial cells) following the induction of acute or chronic intestinal inflammation. These experiments will mechanistically address, in an in vivo setting, if IL-18 derived from specific mucosal cell populations and expressed during the acute versus chronic phases of disease, are involved in the pathogenesis of IBD. The ultimate goal of the present research proposal is to define the precise role of IL-18 in CD in order to develop specific treatment modalities aimed at modifying the natural course of this devastating disease.", 
    "endDate": "2012-08-31T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.419635.c", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2496788", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "2496788"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R01DK056762"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "IL-18 promoter polymorphisms", 
      "addition", 
      "disorders", 
      "acute phase", 
      "IL-18 promoter region", 
      "different mucosal cell populations", 
      "polymorphic IL-18 gene regulation", 
      "transcriptional control", 
      "genetic markers", 
      "IBD multiplex families", 
      "important role", 
      "vivo setting", 
      "reporter", 
      "mutagenesis experiments", 
      "epithelial cells", 
      "several chronic Thl", 
      "vivo", 
      "intestinal epithelial cells", 
      "regulation", 
      "gut mucosa", 
      "expression", 
      "present study", 
      "precise function", 
      "macrophages", 
      "disease", 
      "fact", 
      "mechanismCs", 
      "devastating disease", 
      "present proposal", 
      "allelic variants", 
      "key role", 
      "chronic phase", 
      "contrast", 
      "environmental factors", 
      "dendritic cells", 
      "Recent evidence", 
      "inflammatory bowel disease", 
      "association approach", 
      "creation", 
      "results", 
      "novel function", 
      "IL-18", 
      "macrophage cell line", 
      "central hypothesis", 
      "chronic intestinal inflammation characteristic", 
      "order", 
      "primary source", 
      "IL-18 expression", 
      "immune cells", 
      "relationship", 
      "IBD susceptibility", 
      "marker locus", 
      "Recent studies", 
      "mucosal", 
      "linkage disequilibrium", 
      "transmission patterns", 
      "Crohn's disease", 
      "immune response", 
      "specific single nucleotide polymorphisms", 
      "polymorphism", 
      "natural course", 
      "synthesis", 
      "cells", 
      "dysregulated mucosal", 
      "normal innate immune response", 
      "acute versus", 
      "hemopoietic-", 
      "specific treatment modalities", 
      "role", 
      "specific aim", 
      "differences", 
      "specific role", 
      "vitro transfection assays", 
      "subsequent transcriptional regulation", 
      "pathogenic role IL-18", 
      "protective factors", 
      "precise role", 
      "putative disease susceptibility loci", 
      "predisposed individuals", 
      "specific mucosal cell populations", 
      "control population", 
      "Thl", 
      "different gut mucosal cell populations", 
      "different intestinal cell types", 
      "experimental model", 
      "hypothesis", 
      "sites", 
      "functional relevance", 
      "cytokines", 
      "disease increases", 
      "extent", 
      "precise etiology", 
      "molecular biology techniques", 
      "case association studies", 
      "induction", 
      "several autoimmune diseases", 
      "differential transcription factor", 
      "present research proposal", 
      "dysregulation", 
      "specific genetic factors", 
      "experiments", 
      "association", 
      "chronic intestinal inflammation", 
      "inflammation", 
      "pathogenesis", 
      "genetic basis", 
      "mice", 
      "dramatic shift", 
      "intestinal inflammation", 
      "IL- 18 gene", 
      "ultimate goal", 
      "severity"
    ], 
    "name": "Role of IL-18 in Crohn's Disease (CD)", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.67105.35", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.67105.35", 
          "name": "CASE WESTERN RESERVE UNIVERSITY", 
          "type": "Organization"
        }, 
        "familyName": "PIZARRO", 
        "givenName": "THERESA TORRES", 
        "id": "sg:person.014573405571.67", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.014573405571.67", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2496788"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T12:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_8.xml.gz", 
    "startDate": "2000-07-01T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=7682959"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2496788'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2496788'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2496788'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2496788'


 

This table displays all metadata directly associated to this object as RDF triples.

156 TRIPLES      19 PREDICATES      134 URIs      126 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.2496788 schema:about anzsrc-for:2211
2 schema:amount N63be2e191054497fa8864ef8fd18587a
3 schema:description Although the precise etiology is unknown, inflammatory bowel disease (IBD) is thought to occur as a result of a dysregulated mucosal immune response to environmental factors in a genetically predisposed individual. IL-18 is a cytokine that plays an important role in the pathogenesis of several chronic Thl-mediated disorders, including Crohn's disease (CD). In fact, a dramatic shift in IL-18 expression occurs during CD from intestinal epithelial cells (IEC) to mucosal immune cells (i.e. macrophages and dendritic cells), as the severity of disease increases. In addition, recent evidence supports the role of IL-18 as a protective factor during the acute phase of mucosal immune responses, when IEC are the primary source of IL-18. This novel function for IL-18 contrasts with the pathogenic role IL-18 is believed to play in more chronic phases of Thl-mediated inflammation. A genetic basis for differences in IL-18 regulation and expression observed in IBD may exist since recent studies have reported the association of specific single nucleotide polymorphisms (SNPs) in the IL-18 promoter region and several autoimmune diseases. Therefore, using genetic and molecular biology techniques as well as experimental models intestinal inflammation, the present study is designed to investigate the specific genetic factors that regulate IL-18 synthesis and to determine the precise function of epithelial and immune cell-derived IL-18 in the acute versus chronic phases of IBD. The central hypothesis of the present proposal is that IL-18plays a key role in regulating normal innate immune responses in the gut mucosa and dysregulation of IL-18 may result in chronic intestinal inflammation characteristic of IBD. The following three specific aims are proposed to test this hypothesis: 1) Determine the relationship between polymorphisms in the IL-18 promoter region and IBD. The role of IL-18 in IBD susceptibility will be defined using an association approach by screening for recently described IL-18 promoter polymorphisms and performing case association studies of these genetic markers in well-characterized IBD and control populations. IBD multiplex families will also be used to test linkage disequilibrium between these marker loci and putative disease susceptibility loci in order to further characterize the transmission pattern of allelic variants. 2) Define the mechanismCs) of polymorphic IL-18 gene regulation in different mucosal cell populations. The functional relevance of IL-18 promoter polymorphisms will be achieved by creation of reporter constructs, site-directed mutagenesis experiments, and in vitro transfection assays in epithelial and macrophage cell lines. In addition, differential transcription factor binding and subsequent transcriptional regulation will be assessed in order to determine how the IL- 18 gene is differentially regulated by IL-18 promoter polymorphisms, and if transcriptional control varies among different intestinal cell types. 3) Evaluate the specific role of IL-18 derived from different gut mucosal cell populations in an in vivo setting using experimental models of intestinal inflammation. The extent and severity of disease will be assessed in mice genetically- and immunologically-manipulated to produce IL-18 in either hemopoietic- (i.e. immune cells) or non-hemopoietic-cells (i.e. epithelial cells) following the induction of acute or chronic intestinal inflammation. These experiments will mechanistically address, in an in vivo setting, if IL-18 derived from specific mucosal cell populations and expressed during the acute versus chronic phases of disease, are involved in the pathogenesis of IBD. The ultimate goal of the present research proposal is to define the precise role of IL-18 in CD in order to develop specific treatment modalities aimed at modifying the natural course of this devastating disease.
4 schema:endDate 2012-08-31T00:00:00Z
5 schema:funder https://www.grid.ac/institutes/grid.419635.c
6 schema:identifier N8086c99b624a46d89764de5fba7ee4ed
7 Nfdf40d8d862a4dbfbbc374b95cb82d82
8 schema:inLanguage en
9 schema:keywords Crohn's disease
10 IBD multiplex families
11 IBD susceptibility
12 IL- 18 gene
13 IL-18
14 IL-18 expression
15 IL-18 promoter polymorphisms
16 IL-18 promoter region
17 Recent evidence
18 Recent studies
19 Thl
20 acute phase
21 acute versus
22 addition
23 allelic variants
24 association
25 association approach
26 case association studies
27 cells
28 central hypothesis
29 chronic intestinal inflammation
30 chronic intestinal inflammation characteristic
31 chronic phase
32 contrast
33 control population
34 creation
35 cytokines
36 dendritic cells
37 devastating disease
38 differences
39 different gut mucosal cell populations
40 different intestinal cell types
41 different mucosal cell populations
42 differential transcription factor
43 disease
44 disease increases
45 disorders
46 dramatic shift
47 dysregulated mucosal
48 dysregulation
49 environmental factors
50 epithelial cells
51 experimental model
52 experiments
53 expression
54 extent
55 fact
56 functional relevance
57 genetic basis
58 genetic markers
59 gut mucosa
60 hemopoietic-
61 hypothesis
62 immune cells
63 immune response
64 important role
65 induction
66 inflammation
67 inflammatory bowel disease
68 intestinal epithelial cells
69 intestinal inflammation
70 key role
71 linkage disequilibrium
72 macrophage cell line
73 macrophages
74 marker locus
75 mechanismCs
76 mice
77 molecular biology techniques
78 mucosal
79 mutagenesis experiments
80 natural course
81 normal innate immune response
82 novel function
83 order
84 pathogenesis
85 pathogenic role IL-18
86 polymorphic IL-18 gene regulation
87 polymorphism
88 precise etiology
89 precise function
90 precise role
91 predisposed individuals
92 present proposal
93 present research proposal
94 present study
95 primary source
96 protective factors
97 putative disease susceptibility loci
98 regulation
99 relationship
100 reporter
101 results
102 role
103 several autoimmune diseases
104 several chronic Thl
105 severity
106 sites
107 specific aim
108 specific genetic factors
109 specific mucosal cell populations
110 specific role
111 specific single nucleotide polymorphisms
112 specific treatment modalities
113 subsequent transcriptional regulation
114 synthesis
115 transcriptional control
116 transmission patterns
117 ultimate goal
118 vitro transfection assays
119 vivo
120 vivo setting
121 schema:name Role of IL-18 in Crohn's Disease (CD)
122 schema:recipient Na62a095c5a54400daf223fa39b59b81c
123 sg:person.014573405571.67
124 https://www.grid.ac/institutes/grid.67105.35
125 schema:sameAs https://app.dimensions.ai/details/grant/grant.2496788
126 schema:sdDatePublished 2019-03-07T12:15
127 schema:sdLicense https://scigraph.springernature.com/explorer/license/
128 schema:sdPublisher N471b45afa1754ccfbaeb8f792fef157e
129 schema:startDate 2000-07-01T00:00:00Z
130 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=7682959
131 sgo:license sg:explorer/license/
132 sgo:sdDataset grants
133 rdf:type schema:MonetaryGrant
134 N471b45afa1754ccfbaeb8f792fef157e schema:name Springer Nature - SN SciGraph project
135 rdf:type schema:Organization
136 N63be2e191054497fa8864ef8fd18587a schema:currency USD
137 schema:value 2327791
138 rdf:type schema:MonetaryAmount
139 N8086c99b624a46d89764de5fba7ee4ed schema:name dimensions_id
140 schema:value 2496788
141 rdf:type schema:PropertyValue
142 Na62a095c5a54400daf223fa39b59b81c schema:member sg:person.014573405571.67
143 schema:roleName PI
144 rdf:type schema:Role
145 Nfdf40d8d862a4dbfbbc374b95cb82d82 schema:name nih_id
146 schema:value R01DK056762
147 rdf:type schema:PropertyValue
148 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
149 rdf:type schema:DefinedTerm
150 sg:person.014573405571.67 schema:affiliation https://www.grid.ac/institutes/grid.67105.35
151 schema:familyName PIZARRO
152 schema:givenName THERESA TORRES
153 rdf:type schema:Person
154 https://www.grid.ac/institutes/grid.419635.c schema:Organization
155 https://www.grid.ac/institutes/grid.67105.35 schema:name CASE WESTERN RESERVE UNIVERSITY
156 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...